These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2874230)

  • 1. Neuroleptics and epilepsy in mentally handicapped patients.
    James DH
    J Ment Defic Res; 1986 Jun; 30 ( Pt 2)():185-9. PubMed ID: 2874230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involuntary orofacial movements in hospitalised patients with mental handicap or epilepsy: relationship to developmental/intellectual deficit and presence or absence of long-term exposure to neuroleptics.
    Youssef HA; Waddington JL
    J Neurol Neurosurg Psychiatry; 1988 Jun; 51(6):863-5. PubMed ID: 2900294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic and antiepileptic treatment in the mentally retarded.
    Brodtkorb E; Sand T; Strandjord RE
    Seizure; 1993 Sep; 2(3):205-11. PubMed ID: 7909268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability.
    Leunissen CL; de la Parra NM; Tan IY; Rentmeester TW; Vader CI; Veendrick-Meekes MJ; Aldenkamp AP
    Res Dev Disabil; 2011; 32(6):2660-8. PubMed ID: 21752594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vigabatrin in epilepsy in mentally retarded patients.
    Matilainen R; Pitkänen A; Ruutiainen T; Mervaala E; Riekkinen P
    Br J Clin Pharmacol; 1989; 27 Suppl 1(Suppl 1):113S-118S. PubMed ID: 2757902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment with antiepileptic agents in patients with mental retardation and multiple handicaps].
    Brodtkorb E
    Tidsskr Nor Laegeforen; 2001 Mar; 121(7):834-5. PubMed ID: 11301710
    [No Abstract]   [Full Text] [Related]  

  • 7. Dyskinesia in mentally handicapped women: relationship to level of handicap, age and neuroleptic exposure.
    Farren CK; Dinan TG
    Acta Psychiatr Scand; 1994 Sep; 90(3):210-3. PubMed ID: 7810345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the clinical outcome of patients with profound mental retardation gradually withdrawn from chronic neuroleptic medication.
    May P; London EB; Zimmerman T; Thompson R; Mento T; Spreat S
    Ann Clin Psychiatry; 1995 Dec; 7(4):155-60. PubMed ID: 8721888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of pregabalin in patients with difficult-to-treat epilepsy and intellectual disability.
    Huber B; Bocchicchio M; Feuerbaum E; May T; Meinert T; Robertson E; Schorlemmer H; Wagner W; Wilking E; Seidel M
    Epilepsy Behav; 2008 Aug; 13(2):397-401. PubMed ID: 18554985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic-induced parkinsonian side effects in the mentally handicapped.
    Rao JM; Cowie VA; Mathew B
    J Ment Defic Res; 1989 Feb; 33 ( Pt 1)():81-6. PubMed ID: 2564436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and therapeutic monitoring of epilepsy in a mental handicap unit.
    Collacott RA; Dignon A; Hauck A; Ward JW
    Br J Psychiatry; 1989 Oct; 155():522-5. PubMed ID: 2611575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic population.
    Cohen S; Khan A; Zheng Y; Chiles J
    Acta Psychiatr Scand; 1991 Mar; 83(3):234-7. PubMed ID: 1674398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavior disorders in persons with mental retardation receiving antipsychotic medication.
    Ono Y
    Res Dev Disabil; 1998; 19(2):123-30. PubMed ID: 9547524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in antipsychotic drug dosage in mentally handicapped patients. A hospital study.
    Wressell SE; Tyrer SP; Berney TP
    Br J Psychiatry; 1990 Jul; 157():101-6. PubMed ID: 1975757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudoakathisia: a review and two case reports.
    Stubbs JH; Halstead SM
    Compr Psychiatry; 2000; 41(1):70-2. PubMed ID: 10646622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The abrupt withdrawal of antiparkinsonian drugs in mentally handicapped patients.
    Carter G
    Br J Psychiatry; 1983 Feb; 142():166-8. PubMed ID: 6132644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Motor disorders of the mentally handicapped.
    Kohen D; Mathew G
    Br J Psychiatry; 1991 Apr; 158():571. PubMed ID: 1675904
    [No Abstract]   [Full Text] [Related]  

  • 18. Folate metabolism and problem behaviour in mentally handicapped epileptics.
    Deb S; Cowie VA; Richens A
    J Ment Defic Res; 1987 Jun; 31 ( Pt 2)():163-8. PubMed ID: 3625762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compliance for anticonvulsant medication in an institution for mentally retarded.
    Alvarez N
    Clin Electroencephalogr; 1982 Apr; 13(2):103-7. PubMed ID: 7094351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Akathisia in neuroleptic medicated mentally handicapped subjects.
    Ganesh S; Murti Rao JM; Cowie VA
    J Ment Defic Res; 1989 Aug; 33 ( Pt 4)():323-9. PubMed ID: 2570159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.